Tokyo, May 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061556) titled 'Preventive effect of prophylactic pancreatic duct stenting with endoscopic sphincterotomy for post-ERCP pancreatitis in PGW-assisted bile duct canulation' on May 13.
Study Type:
Observational
Primary Sponsor:
Institute - Division of Minimally Invasive Cancer Treatment, NHO Kure Medical Center and Chugoku Cancer Center
Condition:
Condition - Biliary tract disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Preventive effect of prophylactic pancreatic duct stenting with endoscopic sphincterotomy for post-ERCP pancreatitis in PGW-assisted bile duct canulation
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with PGW-assisted biliary canulation
Key exclusion criteria - Patients with altered intestine after surgery
Target Size - 900
Recruitment Status:
Recruitment status - Main results already published
Date of protocol fixation - 2025 Year 08 Month 31 Day
Date of IRB - 2025 Year 09 Month 01 Day
Anticipated trial start date - 2026 Year 01 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070432
Disclaimer: Curated by HT Syndication.
